25 May 2013
Keywords: promising, mid-stage, data, apixaban, acs, drug, majors
Article | 08 September 2008
US drug majors Bristol-Myers Squibb and Pfizer have reported encouraging results from APPRAISE-1, a Phase II dose-ranging study testing their
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
24 May 2013
© 2013 thepharmaletter.com